A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders
Launched by BUNDANG CHA HOSPITAL · Mar 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking for ways to identify autism spectrum disorder (ASD) in children and teenagers at an early stage. Researchers want to develop a new screening tool that uses eye tracking and motion analysis, which means they will observe how children look at things and move around to gather important information. This study is currently recruiting participants under 19 years old, and it’s open to everyone, regardless of gender.
To participate, children must be healthy without any significant hearing or vision issues that could affect their involvement. Parents or guardians will need to agree to join the study after learning all the details and understanding the process fully. Participants can expect to take part in activities that help researchers learn about their behavior and movement patterns. This is an important step towards creating better tools for early diagnosis of ASD, which can lead to earlier support and intervention for children who need it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children and adolescents under the age of 19 at the time of registration
- • A person whose legal representative voluntarily decides to participate and agrees in writing to comply with the precautions after receiving a detailed explanation of this study and fully understanding it
- Exclusion Criteria:
- • Those with abnormalities in hearing and vision
- • Those who are likely to have difficulty participating in the study according to the judgment of the clinical investigator
- • If the visits set out in this research plan are not followed or the patient's guardian does not cooperate due to low understanding of the patient.
About Bundang Cha Hospital
Bundang CHA Hospital is a leading healthcare institution located in South Korea, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, the hospital leverages its advanced facilities and multidisciplinary expertise to conduct rigorous clinical studies across various therapeutic areas. With a focus on advancing medical knowledge and improving treatment outcomes, Bundang CHA Hospital collaborates with a network of esteemed researchers and healthcare professionals to ensure the highest standards of clinical excellence and ethical practices in all its trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported